Search results
Quavo's diss song gets mixed reaction from fans and Breezy
Rolling Out· 2 days agoQuavo flashed his claws and fangs in his diss track response to Chris Brown's volcanic "Weakest...
David Meehan calls out state for 'same excuse' in YDC trial
New Hampshire Union Leader, Manchester via Yahoo News· 2 days agoApr. 22—A judge had to temper David Meehan Monday afternoon during testimony about the state's approach to defending against a lawsuit he filed on alleged abuse at the state's ...
Mutual of America Capital Management LLC Has $3.33 Million Position in Alkermes plc (NASDAQ:ALKS)
ETF DAILY NEWS· 7 days agoMutual of America Capital Management LLC raised its position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 87.9% during the 4th quarter, according to the company in its most recent ...
3 Biotech Stocks With Skyrocketing Potential: April 2024
InvestorPlace· 14 hours agoInvesting in biotech stocks is not for the faint of heart. The companies in the biotech space are...
HC Wainwright Comments on Reviva Pharmaceuticals Holdings, Inc.’s Q1 2025 Earnings (NASDAQ:RVPH)
ETF DAILY NEWS· 2 days agoReviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Reviva Pharmaceuticals in a research ...
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Zacks via Yahoo Finance· 2 days agoAlkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate...
Quavo Drops Scathing Chris Brown Diss "Over Hoes & B*tches"
HotNewHipHop· 2 days agoChris Brown declared war on Quavo with his last diss, and the Migos rapper has responded with an assist from Takeoff.
Machine Learning Helps Scientists Locate the Neurological Origin of Psychosis
ExtremeTech· 7 days agoAround 3 in every 100 people will experience at least one psychotic episode in their lifetimes. Commonly misunderstood, these episodes are characterized by hallucinations (a false perception ...
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Zacks· 3 days agoAlkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
Rewiring Reality: Stanford Unveils the Brain’s Fault Lines in Psychosis
SciTechDaily· 1 day agoWhen the brain has trouble filtering incoming information and predicting what’s likely to happen,...
